Specific Effect of BRAF-Inhibitors on a BRAF-mutant and a Wild-type Cell Line of Malignant Melanoma

被引：0
|
作者：
Steck, M. [1 ]
Grabenbauer, M. [1 ]
Fuenfle, R. [1 ]
Hecht, M. [1 ]
Fietkau, R. [1 ]
Distel, L., V [1 ]
机构：
[1] Friedrich Alexander Univ Erlangen Nurnberg, Strahlenklin, Erlangen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2017年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P22-5-jD
引用
收藏
页码：S169 / S170
页数：2
相关论文
共 50 条
  • [1] BRAF and MEK inhibitors in BRAF-mutant melanoma
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2012, 13 (11): : E468 - E468
  • [2] Multiple BRAF Wild-Type Melanomas During Dabrafenib Treatment for Metastatic BRAF-Mutant Melanoma
    Carrera, Cristina
    Puig-Butille, Joan A.
    Tell-Marti, Gemma
    Garcia, Adriana
    Badenas, Celia
    Alos, Llucia
    Puig, Susana
    Malvehy, Josep
    JAMA DERMATOLOGY, 2015, 151 (05) : 544 - 548
  • [3] Resistance to BRAF and MEK inhibitors in BRAF-mutant melanoma
    Patel, Hima
    Yacoub, Nour
    Garrett, Joan T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB43 - AB43
  • [4] Arthralgia as a Side Effect of BRAF-Inhibitors in Patients with Malignant Melanoma
    Salzmann, M.
    Buder-Bakhaya, K.
    Benesova, K.
    Dimitrakopoulou-Strauss, A.
    Hassel, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 13 - 13
  • [5] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    Aya, F.
    Fernandez-Martinez, A.
    Gaba, L.
    Victoria, I.
    Tosca, M.
    Pineda, E.
    Gascon, P.
    Prat, A.
    Arance, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (01): : 119 - 124
  • [6] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    F. Aya
    A. Fernandez-Martinez
    L. Gaba
    I. Victoria
    M. Tosca
    E. Pineda
    P. Gascon
    A. Prat
    A. Arance
    Clinical and Translational Oncology, 2017, 19 : 119 - 124
  • [7] BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma
    Paoluzzi, Luca
    Hanniford, Douglas
    Sokolova, Elena
    Osman, Iman
    Darvishian, Farbod
    Wang, Jinhua
    Bradner, James E.
    Hernando, Eva
    CANCER MEDICINE, 2016, 5 (06): : 1183 - 1193
  • [8] BRAF inhibitors: efficacious and tolerable in BRAF-mutant acral and mucosal melanoma
    Bai, X.
    Mao, L. L.
    Chi, Z. H.
    Sheng, X. N.
    Gui, C. L.
    Kong, Y.
    Dai, J.
    Wang, X.
    Li, S. M.
    Tang, B. X.
    Lian, B.
    Zhou, L.
    Yan, X. Q.
    Guo, J.
    Si, L.
    NEOPLASMA, 2017, 64 (04) : 626 - 632
  • [9] Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines
    Tanami, H
    Imoto, I
    Hirasawa, A
    Yuki, Y
    Sonoda, I
    Inoue, J
    Yasui, K
    Misawa-Furihata, A
    Kawakami, Y
    Inazawa, J
    ONCOGENE, 2004, 23 (54) : 8796 - 8804
  • [10] BRAF wild-type malignant melanoma developing on a thermal burn
    Grimaux, Xavier
    Dequidt, Isabelle Massardier
    Michalak, Sophie
    Le Clec'h, Christian
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 (04) : 329 - 330
12345